JEANNETTE RODRIGUEZ: Open Payments
NPI 1043305469 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,116 in 54 payments from 10 companies in 2025. Trend: 2023 $627 · 2024 $1,066 · 2025 $1,116
Food & beverage: $1,116
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $330 |
| Novo Nordisk Inc | 17 | $318 |
| AstraZeneca Pharmaceuticals LP | 9 | $172 |
| Lilly USA, LLC | 5 | $92 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $50 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| ABBVIE INC. | 2 | $32 |
| ViiV Healthcare Company | 1 | $22 |
| Exact Sciences Corporation | 1 | $17 |
Products named: Kerendia, Rybelsus, Ozempic, JARDIANCE, FARXIGA, SPRAVATO, TRELEGY ELLIPTA, QULIPTA.
Industry payments across TX — which companies pay providers there.
